Tag
InMed Pharmaceuticals Inc.
- InMed Pharmaceuticals publicizes new peer-reviewed study
- InMed Pharma rolls out rare cannabinoid via BayMedica
- InMed Pharmaceuticals reports net loss of US$10.2M
- Preclinical results for InMed's CBN glaucoma treatment show promise
- Cannabinol (CBN) the main ingredient in potential treatments for glaucoma and a rare skin disease